Montero SG, Hernández RG, Vega CJC, Ramírez CM

Language: Spanish
References: 26
Page: 11-20
PDF size: 333.13 Kb.

ABSTRACT

The incidence of pneumonia increases with age and contributes to morbidity and mortality in the elderly. This article reviews current concepts in management of pneumonia in the elderly, risk stratification, antibiotic and adjuvant treatment. Emphasize is being made in preventive aspects and considerations regarding geriatric assessment.

REFERENCES

1. Calle A, Márquez MA, Arellano M, et al. Valoración geriátrica y factores pro-nósticos de mortalidad en pacientes muy ancianos con neumonía extrahospi-talaria. Arch Bronconeumol. 2014; 50(10): 429–434.

2. Bagilet D , Yiguerimian L, Settecase C et al. Neumonía adquirida en la comu-nidad en el anciano. Rev Esp Geriatr Gerontol. 2006; 41(1):7-12.

3. Serra Sanchis B, Martínez Moragón E, Aguar M, et al. Neumonía en la pobla-ción mayor de 70 años y con estado funcional limitado: estudio caso-control de pacientes institucionalizados. Rev Clin Esp. 2007; 207(11): 548-554.

4. García-Ordóñez MA, García-Jiménez JM, Páez F, et al. Clinical Aspects and Prognostic Factors in Elderly Patients Hospitalised for Community-Acquired Pneumonia. Eur J Clin Microbiol Infect Dis. 2001; 20:14–19.

5. Torres OH, Gil E, Comas M, et al. Im-pacto de una intervención multidimen-sional en pacientes ≥ 65años tras un in-greso por neumonía: estudio aleatoriza-do. Rev Esp Geriatr Gerontol. 2015.http://dx.doi.org/10.1016/j.regg.2015.09.004.

6. Torres O, Gil E, Pacho C, et al. Actua-lización de la neumonía en el adulto mayor. Rev Esp Geriatr Gerontol. 2013; 48(2): 72–78.

7. González del Castillo J, Martín-Sánchez F, Llinares P, et al. Guía de consenso para el abordaje de la neumonía adqui-rida en la comunidad en el paciente an-ciano. Rev Esp Geriatr Gerontol. 2014; 49(6): 279-291.

8. Mendoza Ruiz de Zuazu H , Aizpuru Barandiaran F, Tiberio López G, et al. Situación inmune en el anciano con neumonía durante el episodio agudo y tras el alta. Rev Esp Geriatr Gerontol. 2007; 42(1): 35-42.

9. Faverio P, Aliberti S , Bellelli G, et al. The management of community-acquired pneumonia in the elderly. Eu-ropean Journal of Internal Medicine. 2014; 25: 312–319.

10. Martín-Salvador A, Torres-Sánchez I, Sáez-Roca G, et al. Estudio del deterio-ro psicofísico y funcional en pacientes ingresados con neumonía. Análisis por grupos de edad. Arch Bronconeumol. 2015;51 (10): 496–501.

11. Jürschik Giménez P, Escobar Bravo MA, Nuin Orrio C, et al. Criterios de fragilidad del adulto mayor. Estudio pi-loto. Aten Primaria. 2011; 43(4): 190—196.

12. Vila-Córcoles A, Ansa X, Ochoa-Gondar O, et al. Pneumococcal pneu-monia in adults 60 years or older: Inci-dence, mortality and prevention. Med Clin (Barc). 2015. http://dx.doi.org/10.1016/j.medcli.2015.09.015.

13. Quesada, O. Vacunas en el horizonte. AMPMD. 2015; 172:1-25.

14. Cabré M, Almirall J, Clave P. Aspira-tion pneumonia: management in Spain. European Geriatric Medicine 2011; 2: 180–183.

15. Puisieux F, D’Andrea C, Baconnier P, et al. Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly. Revue des Maladies Res-piratoires. 2011; 28: e76—e93.

16. Postma DF, van Werkhoven CH, van Elden LJ, et al, for the CAP-START Study Group. Antibiotic treatment stra-tegies for community-acquired pneu- monia in adults. N Engl J Med 2015; 372: 1312–23.

17. O’Brien ME, Restrepo MI, Martin-Loeches I. Update on the combination effect of macrolide antibiotics in com-munity-acquired pneumonia. Respira-tory investigation 2015; 53: 201–209.

18. Ye X, Ma J, Hu B et al. Improvement in clinical and economic outcomes with empiric antibiotic therapy covering atypical pathogens for community- ac-quired pneumonia patients: a multicen-ter cohort study. International Journal of Infectious Diseases 2015; 40: 102–107.

19. Prina E, Ranzani O, Torres A. Commu-nity-acquired pneumonia. Lancet 2015; 386: 1097–108.

20. Caja Costarricense del Seguro Social. Gerencia Médica. Dirección de Farma-coepidemiología. Lista Oficial de Medi-camentos, 2014.

21. Li JZ, Winston LG, Moore DH, Bent S. Efficacy of short-course antibiotic re-gimens for community-acquired pneu-monia: a meta-analysis. Am J Med 2007; 120: 783–90.

22. Choudhury G, Mandal P, Singanayagam A, Akram AR, Chalmers JD, Hill AT. Seven-day antibiotic courses have simi-lar efficacy to prolonged courses in se-vere community-acquired pneumonia—a propensity-adjusted analysis. Clin Microbiol Infect 2011; 17: 1852–58.

23. Rossio R, Franchi C, Ardoino I, et al. Adherence to antibiotic treatment guide-lines and outcomes in the hospitalized elderly with different types of pneumo-nia. European Journal of Internal Me-dicine 2015; 26: 330–337.

24. Giannella M, Pinilla B, Capdevila JA, et al. Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect. 2012; 18: 786–794.

25. Blum C, Nigro N, Briel M, et al. Ad-junct prednisone therapy for patients with community acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2015; 385: 1511–18.

26. Akram AR, Chalmers JD, Taylor JK, et al. An evaluation of clinical stability criteria to predict hospital course in 6. Torres O, Gil E, Pacho C, et al. Actua-lización de la neumonía en el adulto mayor. Rev Esp Geriatr Gerontol. 2013; 48(2): 72–78.